|
|
|
|
LEADER |
01900nam a22002895i 4500 |
001 |
000286091 |
005 |
20211119075820.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387788180
|
024 |
7 |
|
|a 10.1007/978-0-387-78818-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Innovative Endocrinology of Cancer /
|c edited by Lev M. Berstein, Richard J. Santen.
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2008.
|
300 |
|
|
|a XX, 242 p. 54 illus., 1 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 630
|
505 |
0 |
|
|a Mechanisms of Hormone Carcinogenesis: -- Adaptation to Estradiol Deprivation Causes Up-Regulation of Growth Factor Pathways and Hypersensitivity to Estradiol in Breast Cancer Cells -- Role of Endocrine-Genotoxic Switchings in Cancer and Other Human Diseases: -- Breast Development, Hormones and Cancer -- Epidemiology of Hormone-Associated Cancers as a Reflection of Age -- Obesity and Diabetes Epidemics: -- Progesterone Receptor Action: -- Aromatase Expression in Women’s Cancers -- Proteomics of Cancer of Hormone-Dependent Tissues -- Endogenous Hormone Levels and Risk of Breast, Endometrial and Ovarian Cancers: -- Hormonal Heterogeneity of Endometrial Cancer -- Cell Cycle Machinery: -- Selective Estrogen Modulators as an Anticancer Tool: -- Pharmacogenomics of Endocrine Therapy in Breast Cancer -- Prevention of Breast Cancer Using SERMs -- General Conclusion.
|
650 |
|
0 |
|a Cancer research.
|
650 |
1 |
4 |
|a Cancer Research.
|
700 |
1 |
|
|a Berstein, Lev M.
|e editor.
|
700 |
1 |
|
|a Santen, Richard J.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|